Latest Safety News

Page 110 of 146
New Hope Corporation reports steady coal production but a 27% drop in EBITDA amid falling prices and rail constraints, prompting revised FY25 guidance.
Maxwell Dee
Maxwell Dee
19 May 2025
Mantle Minerals has secured a $65,000 co-funded drilling grant from the WA Government to advance its Mt Berghaus gold exploration in the Mallina Basin.
Maxwell Dee
Maxwell Dee
16 May 2025
Great Divide Mining is poised to restart operations at its Challenger Gold Mine in Adelong, NSW, marking a pivotal shift from exploration to production with first gold expected imminently.
Maxwell Dee
Maxwell Dee
16 May 2025
Etherstack plc has reported its highest ever half-year cash receipts, surpassing US$7 million in the first half of FY2025, signaling strong momentum and a promising revenue outlook for the year.
Sophie Babbage
Sophie Babbage
16 May 2025
Catalyst Metals has received the final environmental approval to begin mining at its Trident Gold Project, marking a key step in its plan to double production at the Plutonic Gold Belt.
Maxwell Dee
Maxwell Dee
16 May 2025
Chimeric Therapeutics reports encouraging interim results from its ADVENT-AML Phase 1B trial, with two of three newly diagnosed AML patients achieving remission using their novel CORE-NK cell therapy combined with standard treatment.
Ada Torres
Ada Torres
15 May 2025
Paradigm Biopharmaceuticals has secured centralised US ethics approval for its pivotal Phase 3 trial of injectable pentosan polysulfate sodium (iPPS) targeting moderate to severe knee osteoarthritis, setting the stage for patient enrolment in Q3 2025.
Ada Torres
Ada Torres
15 May 2025
Amplia Therapeutics reports a significant milestone in its ACCENT trial, with 15 confirmed partial responses indicating that narmafotinib combined with chemotherapy outperforms chemotherapy alone in advanced pancreatic cancer.
Ada Torres
Ada Torres
15 May 2025
Immutep’s novel immunotherapy combination with KEYTRUDA and chemotherapy shows a 60.8% response rate in first-line non-small cell lung cancer, outperforming historical benchmarks especially in patients with low PD-L1 expression.
Ada Torres
Ada Torres
15 May 2025
Mayne Pharma has voluntarily withdrawn a speaker presentation for its contraceptive NEXTSTELLIS® following an FDA Untitled Letter concerning promotional claims. The company confirms this does not impact sales or its planned merger with Cosette.
Victor Sage
Victor Sage
14 May 2025
Alliance Aviation Services has updated its FY25 financial guidance, aiming for EBITDA between $205-210 million while navigating operational disruptions and planning significant debt reduction by 2026.
Victor Sage
Victor Sage
14 May 2025
Carbine Resources has been granted a long-term mining lease for its Muchea Silica Sand Project, marking a significant step forward while awaiting further regulatory approvals.
Maxwell Dee
Maxwell Dee
14 May 2025